SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-19-006624
Filing Date
2019-02-12
Accepted
2019-02-12 15:47:40
Documents
1
Group Members
JOHN PETRYSESSA CAPITAL GP, LLCSESSA CAPITAL IM GP, LLCSESSA CAPITAL IM, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv513191_sc13ga.htm SC 13G/A 100595
  Complete submission text file 0001144204-19-006624.txt   102252
Mailing Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019 212-257-4410
Sessa Capital (Master), L.P. (Filed by) CIK: 0001618360 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Subject) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89584 | Film No.: 19590560
SIC: 2834 Pharmaceutical Preparations